Narlaprevir (SCH 900518)
98%
- Product Code: 110345
CAS:
865466-24-6
| Molecular Weight: | 707.96 g./mol | Molecular Formula: | C₃₆H₆₁N₅O₇S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Narlaprevir is primarily used in the treatment of chronic hepatitis C virus (HCV) infections. It functions as a protease inhibitor, targeting the NS3/4A protease enzyme essential for viral replication. By inhibiting this enzyme, it prevents the virus from multiplying, thereby reducing the viral load in the body. It is often used in combination with other antiviral medications, such as ribavirin and pegylated interferon, to enhance its efficacy and reduce the risk of resistance. This combination therapy has shown significant success in achieving sustained virological response (SVR), which is indicative of a cure for HCV. Narlaprevir is particularly beneficial for patients with genotype 1 HCV, one of the most challenging strains to treat. Its use has contributed to improving treatment outcomes and reducing the progression of liver disease in affected individuals.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿53,541.00 |
+
-
|
Narlaprevir (SCH 900518)
Narlaprevir is primarily used in the treatment of chronic hepatitis C virus (HCV) infections. It functions as a protease inhibitor, targeting the NS3/4A protease enzyme essential for viral replication. By inhibiting this enzyme, it prevents the virus from multiplying, thereby reducing the viral load in the body. It is often used in combination with other antiviral medications, such as ribavirin and pegylated interferon, to enhance its efficacy and reduce the risk of resistance. This combination therapy has shown significant success in achieving sustained virological response (SVR), which is indicative of a cure for HCV. Narlaprevir is particularly beneficial for patients with genotype 1 HCV, one of the most challenging strains to treat. Its use has contributed to improving treatment outcomes and reducing the progression of liver disease in affected individuals.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :